Detalles de la búsqueda
1.
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials.
Br J Dermatol
; 189(6): 666-673, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708254
2.
Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.
Clin Exp Dermatol
; 48(8): 881-888, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37032446
3.
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.
J Eur Acad Dermatol Venereol
; 37(5): 1036-1045, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36514996
4.
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials.
Br J Dermatol
; 186(6): 1047-1049, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35041213
5.
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes.
Dermatol Ther
; 35(12): e15954, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36270978
6.
Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: results from BRAVE-AA1 and BRAVE-AA2 studies.
J Am Acad Dermatol
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38852742
7.
Antischistosomiasis Liver Fibrosis Effects of Chlorogenic Acid through IL-13/miR-21/Smad7 Signaling Interactions In Vivo and In Vitro.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27872076
8.
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials.
Alzheimers Dement
; 13(10): 1117-1124, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28365320
9.
Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.
BMC Geriatr
; 16: 93, 2016 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27142529
10.
Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort.
Alzheimers Dement
; 12(9): 977-986, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27109039
11.
Protection of Nerve Injury with Exosome Extracted from Mesenchymal Stem Cell.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 38(1): 33-6, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26956853
12.
Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib.
Dermatol Ther (Heidelb)
; 2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38904749
13.
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.
Dermatol Ther (Heidelb)
; 14(6): 1561-1573, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777937
14.
A fusion learning method to subgroup analysis of Alzheimer's disease.
J Appl Stat
; 50(8): 1686-1708, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260470
15.
Robust analyses for radiographic progression in rheumatoid arthritis.
RMD Open
; 9(2)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37015757
16.
[Bushen Anshen acupuncture for perimenopausal insomnia of kidney-yin deficiency: a randomized controlled trial].
Zhongguo Zhen Jiu
; 43(6): 634-8, 2023 Jun 12.
Artículo
en Zh
| MEDLINE | ID: mdl-37313556
17.
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata.
Dermatol Ther (Heidelb)
; 13(12): 3209-3220, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991697
18.
Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials.
J Dermatolog Treat
; 34(1): 2227299, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381691
19.
Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
Adv Ther
; 40(8): 3574-3587, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37332021
20.
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies.
Rheumatol Ther
; 10(2): 463-476, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36662442